The presence of metastases in the lymph nodes of the axillary fossa is the most important prognostic factor in patients with breast cancer. The surgical treatment option required for evaluation of the condition of the axillary lymph nodes depends on the results of a preoperative physical examination of the patients. The aim of the study was to evaluate the correctness of breast cancer patients' qualification to surgical procedures allowing for evaluation of the condition of the axillary lymph nodes. material and methods. A retrospective analysis of a group of 963 patients with a diagnosed malignancy of the breast, treated surgically in the period from 01 Jan 2011 to 29 Feb 2012. Depending on the result of evaluation of the axillary lymph node clinical condition, the patients underwent sentinel lymph node biopsy or elective axillary lymphadenectomy. Results. In 27.4% of patients subjected to excision of the sentinel lymph node, metastatic lesions were found in the lymph nodes removed during the procedure. In most cases (98.1%) that concerned the lymph nodes of the lower part of the axilla. In 17.4% of patients, metastases were located also in the middle or upper part (9%). In the group of patients primarily qualified to lymphadenectomy, the metastatic lesions in the axillary lymph nodes were diagnosed in 67.2% of patients. They were most commonly located in the lower part of the axillary fossa (in 96.7% of cases), and in 68.8% of patients in the middle or upper part (35.8%). conclusions. Biopsy of the sentinel lymph node in patients with clinically advanced breast cancer is an effective and safe method of evaluation of the condition of the axillary fossa lymph nodes. A high rate of false positive results concerning the clinical stage of the disease requires changing the rules of patients' qualification to elective axillary lymphadenectomy. Key words: breast cancer, conserving treatment, axillary lymphadenectomy, sentinel lymph node biopsy, surgical treatment In order to evaluate the clinical advancement of mammary gland epithelial tumour of invasive type it is also necessary to examine the condition of axillary fossa lymph nodes. The presence of metastases in the lymph nodes that are located there is the most important prognostic factor in breast cancer patients, which to the greatest extent influences the long-term treatment results in patients (1).
In order to evaluate the clinical advancement of mammary gland epithelial tumour of invasive type it is also necessary to examine the condition of axillary fossa lymph nodes. The presence of metastases in the lymph nodes that are located there is the most important prognostic factor in breast cancer patients, which to the greatest extent influences the long-term treatment results in patients (1) .
In patients qualified for radical surgical treatment the choice of surgical method necessary for the evaluation of the condition of axillary fossa lymph nodes is determined by the result of clinical examination performed before the procedure. It includes a palpation examination of the nodes as well as the results of imaging tests. The lack of metastases in lymph nodes (cN0 patients) allows for their evaluation using biopsy of a sentinel lymph node (2, 291 Axillary fossa lymph nodes in the radical treatment of breast cancer 3, 4) . On the other hand, the presence of metastases in lymph nodes (cN1 type) requires an elective axillary lymphadenectomy procedure. Depending on a clinical situation the procedure may concern the first and the second or all levels of lymph nodes of axillary fossa (2, 3, 4) in accordance with Berg's division (5) .
The obtained result of the histopathological examination allows for a definite determination of the level of carcinoma advancement. It also significantly determines medical indications for the application of adjuvant treatment (2, 3, 4) .
Both the above-mentioned types of surgeries, especially axillary lymphadenectomy, may contribute to multiple complications. The most significant ones include upper limb edema of the affected side of the body as well as sensory disorders or disorders of functions of particular muscles resulting from the damage of the parts of the peripheral nervous system. The most commonly observed aftermath of lymphadenectomy is the deformity of the layers of axillary fossa area (6, 7, 8) . Thus, the proper qualification of patients with breast cancer for appropriate surgical treatment regarding axillary fossa lymph nodes appears to be of significant importance.
The aim of this study was to evaluate the quality of patients' qualifications for surgical procedures allowing for evaluation of the condition of the axillary fossa lymph nodes in the radical treatment of breast cancer.
MATERIAL AND METHODS
Between 1st January 2011 and 29 February 2012, 963 patients with a confirmed malignant primary tumour of the mammary gland were hospitalised at the Clinical Department of Breast Cancer and Reconstructive Surgery, Oncology Centre in Bydgoszcz.
All patients were treated surgically. 42 female patients (7 with a confirmed mesenchymal malignant tumour, 35 with a pre-invasive intraductal tumour -carcinoma in situ intraductale) did not require axillary fossa lymph nodes assessment. Other four patients (with infiltrating tumour and the presence of distant metastases) underwent surgical, non-radical toilet mastectomy.
The study included 917 patients with invasive breast cancer who underwent a radical surgical treatment. In 566 cases (cN0 patients) a sentinel lymph node biopsy was performed. The patients who were found to have metastases in the dissected lymph node underwent supplementary axillary lymphadenectomy.
The remaining patients (351) with suspicious lymph nodes observed during pre-operative clinical evaluation -group cN1 underwent elective axillary lymphadenectomy on the tumour-affected side of the body.
Pathological data regarding the condition of the dissected lymph nodes obtained from the postoperative report were analysed in the both selected groups of patients. The size and type of metastases found in the lymph nodes were classified in accordance with the standards of American Joint Committee on Cancer (AJCC) (9).
The differences between the studied groups were evaluated using parametric test for two proportions based on normal distribution statistics. A statistically significant difference between the compared data groups were recognised at significance level values of p < 0.05.
RESULTS
In 155 patients who underwent a sentinel node dissection metastatic changes were found in the removed lymph nodes. In one patient (0.6%) they were isolated tumour cellspN0(i+), in 18.7% cases -micrometastases (pN1mi) and in 80.7% of patients -metastases exceeding 2 mm (pN1a). In the majority of cases (98.1%) metastatic changes were located in lymph nodes of a lower level of axillary fossa. In 17.4% of patients they were also confirmed in the middle level, in 8.6% of cases in the upper level (while determining the location of metastatic changes histopathological examination result obtained after the performance of adjuvant lymphadenectomy was considered) -tab. 1.
In the group qualified for elective lymphadenectomy metastatic changes in lymph nodes of axillary fossa were found in 67.2% of the patients. In 229 patients (97%) they were changes exceeding 2 mm in a diameter, in 7 patients (3%) -micrometastases. Most often they were located in the lower level of axillary fossa (in 96.7% of cases), in 68.8% of patients in the middle level or upper level (35.8%) -a detailed distribution of the data is presented in the tab. 1.
During the procedure of sentinel node biopsy on average 2.5 lymph nodes were dissected (in the value range of 1-12 nodes).
As a result of elective lymphadenectomy on average 20.6 nodes (7-44) were obtained and following the dissection of lymph nodes of axillary fossa in patients with metastases in a sentinel node -19.1 lymph nodes . In 97.2% of patients requiring axillary lymphadenectomy procedure, irrespectively of the type of the performed surgery, at least ten lymph nodes were removed. In the case of elective lymphadenectomy the above situation concerned 97.2% of patients (341/351) whereas in the case of adjuvant lymphadenectomy -following the dissection of a sentinel node -97.3% of patients (145/149). The lack of sufficient radicality of the performed procedure concerned 14 patients in total. It did not necessitate in any case the supplementary treatment, designed on the basis of the data from the pathological report (tab. 2), to be modified. This also concerned the indications for the use of postoperative radiotherapy of axillary fossa (tab. 2). Axillary fossa lymph nodes in the radical treatment of breast cancer DISCUSSION A sentinel node biopsy procedure has changed the surgical treatment strategy of a locally advanced breast cancer in a permanent and effective manner. However, in the case of confirmed metastatic changes concerning axillary fossa lymph nodes on the tumour-affected side of the body the most commonly applied therapeutic approach is lymphadenectomy procedure (6, 7, 8) . Most often it concerns situations where the aforementioned changes had been diagnosed before surgical treatment was commenced.
The confirmed in our clinical material presence of metastatic changes in dissected nodes (cN0 patients) in 27.4% of patients who underwent a sentinel node biopsy is similar to the results of the studies performed by Krag et al. (6) and Mansel et al. (7) (28.9% and 30%, respectively). This may partly indicate that preoperative evaluation of clinical advancement of the disease was accurate and the patients were qualified for the appropriate surgical procedure.
In accordance with a physical examination prior to the surgery the percentage of metastatic changes found in axillary fossa lymph nodes of the patients qualified for elective lymphadenectomy was statistically significantly higher than in the group of patients who underwent a sentinel node biopsy (67.2% vs 27.4%, p < 0.0001). Moreover, in the mentioned group of patients metastases more often concerned also higher levels of axillary fossa (p < 0.05), which was of statistical significance.
Almost a third of patients, initially requiring lymphadenectomy procedure (cN1), showed no metastatic changes (pN0) in histopathological examination. Thus, the obtained falsepositive 33% result concerning the preoperative assessment of clinical condition of axillary fossa lymph nodes points to the necessity of the modification of indications for this procedure.
As it appears from the study of Specht et al. the above-mentioned percentage may be lower (10). Their analysis showed a particular clinical situation concerning almost 25% of patients who underwent elective lymphadenectomy. The authors highlight the difficulties related to the unequivocal determination of the rules governing the process of patients' qualification for various surgical procedures. However, so far, apart from a physical examination and US-based evaluation, there has been no effective and at the same time cheap diagnostic method facilitating the choice of optimal surgical procedure.
In the case of the applied in our centre, during conducting of the above presented study (2011), qualification procedure of breast cancer patients for a sentinel node biopsy it was only used in patients who did not have suspicious lymph nodes in axillary fossa. However, if the patients were found to be in an adverse clinical condition (enlarged lymph nodes on palpation as well as coexisting changes noted during ultrasound examination), elective lymphadenectomy was performed. Thus, examination of these changes with the use of minimally invasive procedures (thin needle aspiration biopsy) was not applied routinely, as currently recommended by experts (11).
As it appears from the recommendations presented by the National Consultant for Oncological Surgery, the findings of single, clinically suspicious (on palpation or during imaging examination) lymph nodes, do not necessitate the performance of axillary lymphadenectomy but it requires their verification (thin needle aspiration biopsy) (11). In accordance with the cited recommendation the performance of elective lymphadenectomy in breast cancer patients is possible when the presence of carcinoma cells has been confirmed in axillary fossa lymph nodes. However, if these changes are not confirmed, the patients are required to be qualified for a sentinel node procedure.
The introduction of the above regulations into everyday clinical practice in the centre, where the authors of this paper work, increased the number of patients treated surgically with the aim of saving axillary fossa lymph nodes (from 61.1% in 2011 to 78.9% in the first half of 2014). Similarly, this decreased the percentage of metastatic changes found in lymph nodes (27.4% vs 22.5% -2014) in this group of patients. The presented changes concerning a surgical strategy approach should allow for a limited intensification of adverse consequences characteristic for axillary lymphadenectomy in the treated patients. This is in accordance with the conclusions presented by Krag et al. and the other authors (6, 7, 8) .
In the analysed group the vast majority of patients requiring lymphadenectomy (97.2%) at least ten lymph nodes were found in the tissue material dissected during the surgery. Irrespectively of the applied treatment it allowed for a reliable evaluation of the disease advancement level.
CONCLUSIONS
A sentinel node biopsy procedure in patients with not advanced in clinical evaluation breast cancer is an effective and safe method of assessment of the condition of axillary fossa lymph nodes. The high percentage of false-positive results concerning a clinical level of disease advancement (in the examined material in nearly 33% of patients) requires modifications to the strategy of patients' qualification for elective axillary lymphadenectomy. This may allow for a consideration of currently existing recommendations defining the standards of radical treatment of breast cancer patients in everyday clinical practice.
